Belantamab mafodotin
Showing 51 - 55 of 55
High-Risk de Novo Multiple Myeloma Trial in Spain (Daratumumab, Bortezomib, Lenalidomide)
Not yet recruiting
- High-Risk de Novo Multiple Myeloma
- Daratumumab
- +5 more
-
Badalona, Spain
- +9 more
Apr 27, 2023
Glioblastoma Multiforme Trial in Worldwide (drug, other, radiation)
Terminated
- Glioblastoma Multiforme
- Steroid eye drops
- +6 more
-
Los Angeles, California
- +21 more
Mar 19, 2021
Glioblastoma Trial in Worldwide (Depatuxizumab mafodotin, Temozolomide, Lomustine)
Completed
- Glioblastoma
- Depatuxizumab mafodotin
- +2 more
-
Palo Alto, California
- +101 more
May 8, 2020
Lymphoma, B-cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular, Grade 3b Trial in United States (denintuzumab
Terminated
- Lymphoma, B-cell
- +3 more
- denintuzumab mafodotin
- +4 more
-
Little Rock, Arkansas
- +28 more
Apr 19, 2019
Diffuse, Large B-Cell, Lymphoma, Follicular Lymphoma, Grade 3b, Transformed Lymphoma / DLBCL Trial in Puerto Rico, United States
Terminated
- Diffuse, Large B-Cell, Lymphoma
- +2 more
- denintuzumab mafodotin
- +5 more
-
Birmingham, Alabama
- +34 more
Feb 11, 2019